Home
>
National Drug Code (NDC)
>
Clindesse
Clindesse - 64011-124-27 - (clindamycin phosphate)
Drug Information of Clindesse
| Product NDC: | 64011-124 |
| Proprietary Name: | Clindesse |
| Non Proprietary Name: | clindamycin phosphate |
| Active Ingredient(s): | 20 mg/g & nbsp; clindamycin phosphate |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindesse
| Product NDC: | 64011-124 |
| Labeler Name: | Ther-Rx Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050793 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091101 |
Package Information of Clindesse
| Package NDC: | 64011-124-27 |
| Package Description: | 5 g in 1 APPLICATOR (64011-124-27) |
NDC Information of Clindesse
| NDC Code | 64011-124-27 |
| Proprietary Name | Clindesse |
| Package Description | 5 g in 1 APPLICATOR (64011-124-27) |
| Product NDC | 64011-124 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clindamycin phosphate |
| Dosage Form Name | CREAM |
| Route Name | VAGINAL |
| Start Marketing Date | 20091101 |
| Marketing Category Name | NDA |
| Labeler Name | Ther-Rx Corporation |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
